Research Article
Open Access
The AKT isoforms 1 and 2 drive B cell fate decisions during the germinal center response
View ORCID ProfileZilu Zhu Correspondence email, Ashima Shukla, Parham Ramezani-Rad, John R Apgar, Robert C Rickert
Zilu Zhu
1Tumor Microenvironment and Cancer Immunology Program, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA
2National Cancer Institute-designated Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA
Ashima Shukla
1Tumor Microenvironment and Cancer Immunology Program, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA
2National Cancer Institute-designated Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA
Parham Ramezani-Rad
1Tumor Microenvironment and Cancer Immunology Program, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA
2National Cancer Institute-designated Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA
John R Apgar
1Tumor Microenvironment and Cancer Immunology Program, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA
2National Cancer Institute-designated Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA
Robert C Rickert
1Tumor Microenvironment and Cancer Immunology Program, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA
2National Cancer Institute-designated Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA
Published 25 November 2019. DOI: 10.26508/lsa.201900506
Statistics from Altmetric.com
Article usage
AKT1/2 regulate GC response
Zilu Zhu, Ashima Shukla, Parham Ramezani-Rad, John R Apgar, Robert C Rickert
Life Science Alliance Nov 2019, 2 (6) e201900506; DOI: 10.26508/lsa.201900506
In this Issue
Volume 2, No. 6
December 2019
Advertisement
Jump to section
Subjects
Related Articles
- No related articles found.
Cited By...
- No citing articles found.